The beneficial effect of phosphocreatine accumulation in the creatine kinase transgenic mouse liver in endotoxin-induced hepatic cell death

Journal of Surgical Research

Volumn 80, Issue 2, 1998, Pages 229-235

  Kanazawa, Akiyoshi ^b   Tanaka, Akira ^b   Iwata, Shingo ^b   Satoh, Seiji ^b   Hatano, Etsuro ^b   Shinohara, Hisashi ^b   Kitai, Toshiyuki ^b   Tsunekawa, Shoji ^b   Ikai, Iwao ^b   Yamamoto, Masayuki ^b   Takahashi, Rei ^b   Chance, Britton ^a   Yamaoka, Yoshio ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

Apoptosis; Necrosis; Phosphocreatine; TNF

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINOTRANSFERASE; CREATINE KINASE; CREATINE PHOSPHATE; ENDOTOXIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENERGY METABOLISM; LIVER INJURY; LIVER METABOLISM; LIVER NECROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURVIVAL; TRANSGENIC MOUSE;

EID: 0032417269     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5482     Document Type: Article

References (27)

1. Shimahara Y., Ozawa K., Ida T., Ukikusa M., Tobe T. Role of mitochondrial enhancement in maintaining hepatic energy charge level in endotoxin shock. J. Surg. Res. 33:1982;314.
2. Koretsky A. P., Brosnan M. J., Chen L., Chen J., Dyke T. NMR detection of creatine kinase expressed in liver of transgenic mice: Determination of free ADP levels. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3112.
3. Brosnan M. J., Chen L., Dyke T. A., Koretsky A. P. Free ADP levels in transgenic mouse liver expressing creatine kinase. J. Biol. Chem. 256:1990;20849.
4. Brosnan M. J., Chen L., Wheeler C. E., Van Dyke T. A., Koretsky A. P. Phosphocreatine protects ATP from fructose load in transgenic mouse liver expressing creatine kinase. Am. J. Physiol. 260:1991;C1191.
5. Miller K., Halow J., Koretsky A. P. Phosphocreatine protects transgenic mouse liver expressing creatine kinase from hypoxia and ischemia. Am. J. Physiol. 265:1993;C1544.
6. Willimann T., Wyss M., Brdiczka D., Nicolay K., Eppenberger H. M. Intercellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: The phosphocreatine circuit for cellular energy homeotasis. Biochem. J. 281:1992;21.
7. Walker J. B. Creatine: Biosynthesis, regulation, and function. Adv. Enzymol. Relat. Areas. Mol. Biol. 50:1977;177.
8. Dawson D. M., Fine I. H. Creatine kinase in human tissues. Arch. Neurol. 16:1967;175.
9. Wyss M., Willimann T. Creatine metabolism and the consequences of depletion in muscle. Mol. Cell. Biochem. 133:1994;51.
10. Hatano E., Tanaka A., Iwata S., Satoh S., Kitai T., Tsunekawa S., Inomoto T., Shinohara H., Chance B., Yamaoka Y. Induction of endotoxin tolerance in transgenic mouse liver expressing creatine kinase. Hepatology. 24:1996;663.
11. Satoh S., Tanaka A., Hatano E., Inomot T., Iwata S., Kitai T., Shinohara H., Tsunekawa S., Chance B., Yamaoka Y. Energy metabolism and regeneration in transgenic mouse liver expressing creatine kinase after major hepatectomy. Gastroenterology. 110:1996;1166.
12. Decker K., Keppler D. Rev. Physiol. Biochem. Pharmacol. 71:1974;77.
13. Galanos C., Freudenberg M. A., Reutter W. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. U.S.A. 76:1979;5939.
14. Leist M., Gantner F., Bohlinger I., Tiegs G., Germann P. G., Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver liver failure in experimental murine shock models. Am. J. Pathol. 146:1995;1220.
15. Sellvold O. F. M., Jyunge P., Aarstad K. High performance liquid chromatography: A rapid isocreatic method for determination of creatine compounds and adenine nucleotides in myocardial tissue. J. Mol. Cell Cardiol. 18:1986;517.
16. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell. Biol. 119:1992;493.
17. Su S. M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques; a comparison of ABC and unlabeled antibody (PAP) procedure. J. Histochem. Cytochem. 29:1981;577.
18. Hofmann F., Wagle R. S., Decker K. Effect ofD. Hoppe-Seyler's Z. Physiol. Chem. 357:1976;1395.
19. Rosser B. G., Gores G. J. Liver cell necrosis: Cellular mechanisms and clinical implications. Gastroenterology. 108:1995;252.
20. Morikawa A., Sugiyama T., Kato Y., Koide N., Jiang G. Z., Takahashi K., Tamada Y., Yokochi T. Apoptotic cell death in the response ofD. Infect. Immunol. 64:1996;734.
21. Suteu S., Bandila T., Cafrita A., Bucur A., Candea V. Shock. Pathotogy, metabolism, Shock Cell Treatment. 1977;Abacus press. p. 312-375.
22. Krown K. A., Page M. T., Nguyen C., Zechner D., Guierrez V., Comstock K. L., Glemboltski C. C., Quintana P. J. E., Sabbadini R. A. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J. Clin. Invest. 98:1996;2854.
23. Wallach D., Boldin M., Vrfolmeev E., Beyaert R., Vandenabeele P., Fiers W. Cell death induction by receptors of TNF family: Towards a molecular understanding. FEBS Lett. 410:1997;96.
24. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614.
25. Smets L. A., Van den Berg J., Acton D., Top B., Van Rooji H., Verwijs-Jansesen M. BCL-2 expression and mitochondrial activity in leukemic cells with different sensitivity to glucocorticoid-induced apoptosis. Blood. 84:1994;1613.
26. Skopelitou A., Hadjiyannakis M., Alexopoulou V., Krikoni O., Kamina S., Agnantis N. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions. Anticancer Res. 16:1996;975.
27. Christoph R., Matthias S., Andrea C., Claudio F. Control of apoptosis by cellular ATP level. FEBS Lett. 378:1996;107.